Trial NCT03377101

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2017-02320
Secondary IDs: 10194 NCI-2017-02320 UM1CA186704

Last trial update was posted on 2018-08-14

MeSH Interventions

Fulvestrant Palbociclib

MeSH Conditions

Breast Neoplasms

Other Conditions

Estrogen Receptor Positive HER2/Neu Negative Progesterone Receptor Positive Stage IV Breast Cancer AJCC v6 and v7

Stopping Reasons

change in study design.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID